Co-founded by PureTech Health (LSE: PRTC) and based on the pioneering work of Siddhartha Mukherjee, M.D., D.Phil, as well as Vor's own intellectual property, Vor is developing a proprietary pipeline of best-in-class immunotherapies for patients. The Company is working with some of the world's leading oncologists and immunologists.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/14/19 | $42,000,000 | Series A |
5AM Ventures Johnson & Johnson Innovation Novartis Institute for Biomedical Research Osage University Partners PureTech Health RA Capital Management | undisclosed |
| 07/08/20 | $110,000,000 | Series B |
5AM Ventures Alexandria Venture Investments Fidelity Management & Research Company Johnson & Johnson Innovation Osage University Partners PureTech Health RA Capital Management | undisclosed |
